Breast Cancer Cell Density: Imaging assay of the density- and context-dependence of small molecule perturbagen response in breast cancer cell lines. Dataset 1 of 3: Cell count and normalized growth rate inhibition values. - Dataset (ID:20256)
Download: Excel (XLSX), Comma-separated (CSV)
Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | Replicate | Seeding Density | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value |
---|---|---|---|---|---|---|---|---|---|---|
SK-BR-3 | Nilotinib | 1 | uM | 3 | 1250.00 | 1210.88 | 2872.00 | 2533.13 | 1.1338 | 1.2503 |
SK-BR-3 | PLX-4720 | 0.31623 | uM | 3 | 1250.00 | 1210.88 | 2695.00 | 2533.13 | 1.0639 | 1.1198 |
SK-BR-3 | PLX-4720 | 0.01 | uM | 3 | 1250.00 | 1210.88 | 2334.00 | 2533.13 | 0.9214 | 0.8520 |
SK-BR-3 | Etoposide | 0.031623 | uM | 3 | 1250.00 | 1210.88 | 2354.00 | 2533.13 | 0.9293 | 0.8669 |
SK-BR-3 | Nilotinib | 3.1623 | uM | 3 | 1250.00 | 1210.88 | 2654.00 | 2533.13 | 1.0477 | 1.0895 |
SK-BR-3 | 0 | uM | 3 | 1250.00 | 1210.88 | 2590.00 | 2533.13 | 1.0225 | 1.0421 | |
SK-BR-3 | 0 | uM | 3 | 1250.00 | 1210.88 | 2563.50 | 2533.13 | 1.0120 | 1.0225 | |
SK-BR-3 | 0 | uM | 3 | 1250.00 | 1210.88 | 2236.00 | 2533.13 | 0.8827 | 0.7789 | |
SK-BR-3 | 0 | uM | 3 | 2500.00 | 2418.67 | 3985.00 | 4493.25 | 0.8869 | 0.7486 | |
SK-BR-3 | 0 | uM | 3 | 2500.00 | 2418.67 | 4269.00 | 4493.25 | 0.9501 | 0.8886 | |
SK-BR-3 | Etoposide | 10 | uM | 3 | 2500.00 | 2418.67 | 1746.00 | 4493.25 | 0.3886 | -0.3056 |
SK-BR-3 | PLX-4720 | 0.031623 | uM | 3 | 2500.00 | 2418.67 | 4349.00 | 4493.25 | 0.9679 | 0.9283 |
SK-BR-3 | NVP-TAE684 | 0.031623 | uM | 3 | 2500.00 | 2418.67 | 4300.00 | 4493.25 | 0.9570 | 0.9040 |
SK-BR-3 | 0 | uM | 3 | 2500.00 | 2418.67 | 4350.00 | 4493.25 | 0.9681 | 0.9288 | |
SK-BR-3 | Etoposide | 0.01 | uM | 3 | 2500.00 | 2418.67 | 4494.00 | 4493.25 | 1.0002 | 1.0004 |
SK-BR-3 | NVP-TAE684 | 3.1623 | uM | 3 | 2500.00 | 2418.67 | 2254.00 | 4493.25 | 0.5016 | -0.0759 |
SK-BR-3 | Etoposide | 0.31623 | uM | 3 | 2500.00 | 2418.67 | 2988.00 | 4493.25 | 0.6650 | 0.2669 |
SK-BR-3 | PLX-4720 | 0.0033113 | uM | 3 | 2500.00 | 2418.67 | 4806.00 | 4493.25 | 1.0696 | 1.1564 |
SK-BR-3 | NVP-TAE684 | 0.01 | uM | 3 | 2500.00 | 2418.67 | 4556.00 | 4493.25 | 1.0140 | 1.0313 |
SK-BR-3 | Etoposide | 0.0033113 | uM | 3 | 2500.00 | 2418.67 | 4637.00 | 4493.25 | 1.0320 | 1.0717 |
SK-BR-3 | PLX-4720 | 10 | uM | 3 | 2500.00 | 2418.67 | 4507.00 | 4493.25 | 1.0031 | 1.0069 |
SK-BR-3 | Etoposide | 3.1623 | uM | 3 | 2500.00 | 2418.67 | 2086.00 | 4493.25 | 0.4643 | -0.1526 |
SK-BR-3 | Nilotinib | 19.9526 | uM | 3 | 2500.00 | 2418.67 | 1675.00 | 4493.25 | 0.3728 | -0.3371 |
SK-BR-3 | Nilotinib | 0.1 | uM | 3 | 2500.00 | 2418.67 | 4618.00 | 4493.25 | 1.0278 | 1.0622 |
SK-BR-3 | PLX-4720 | 0.1 | uM | 3 | 2500.00 | 2418.67 | 4472.00 | 4493.25 | 0.9953 | 0.9894 |